Skip to main content

Ultra-conservative groups and big drug companies are suing to block Americans’ access to quality, affordable health care. Ongoing litigation threatens to repeal the Affordable Care Act requirement that insurers cover preventive services without cost sharing, to block Medicare from negotiating lower drug prices, and to throw our drug approval system into chaos by overturning the FDA’s approvals of mifepristone.

Please join Protect Our Care with Former Solicitor General of the United States Don Verrilli and leading legal, economic, and health experts for an in-depth discussion of three key legal battles that threaten Americans’ health care. This event is designed to provide timely and relevant information of use to congressional staff, health care advocates and providers, journalists, and other interested parties.

Date: Tuesday, March 12, 2024
Time: 9 AM – 12 PM ET, Doors will open at 8:30 AM – a light breakfast will be served
Location: SVC 215, U.S. Capitol Visitor Center

Panel conversations will focus on the following cases:

  • Threats to Preventive Care (Braidwood v. Becerra)
    This panel will explore the health care at risk if the ACA’s free preventive services requirement is struck down as this case makes its way through the 5th Circuit Court of Appeals and beyond.

    • Panelists:
      • Georges Benjamin, Executive Director, American Public Health Association
      • Gretchen Borchelt, Vice President for Reproductive Rights and Health, National Women’s Law Center
      • Andrew Pincus, Partner, Mayer Brown
      • Mary Rouvelas, Managing Counsel and Legal Advocacy Director, American Cancer Society Cancer Action Network
  • Threats to Lower Prescription Drug Costs
    This panel will explore the cases seeking to overturn the Medicare Drug Price Negotiation Program, putting lower prescription drug costs at risk for seniors, and the broader implications it has for lowering drug costs for all Americans.

    • Panelists:
      • Gerard Anderson, Professor of health policy and management, Johns Hopkins University Bloomberg School of Public Health
      • Zachary Baron, Director of the Health Policy and the Law Initiative, O’Neill Institute for National & Global Health Law
      • Christine Petrin, Board Chair, Doctors for America
  • Threats to Reproductive Health Care and the Drug Approval System (Alliance for Hippocratic Medicine v. FDA)
    This panel will explore the implications of opening the door for the politically motivated destruction of the FDA’s drug approval process as the Supreme Court prepares to hear the case seeking to ban mifepristone.

    • Panelists:
      • Carrie Flaxman, Senior Advisor, Democracy Forward
      • Jocelyn Frye, President, National Partnership for Women & Families
      • William Schultz, Partner, Zuckerman Spaeder, former General Counsel, Department of Health and Human Services